RESEARCH-USE BIOSIMILAR ANTIBODY

Derlotuximab

Monoclonal antibody · IgG1

DNAIgG1RUO

Derlotuximab is a CHO-expressed, scFv-Fc (huIgG1) type chimeric antibody that targets Histone H1. The predicted molecular weight (MW) of Derlotuximab is 145.1 kDa. The isotype control for Derlotuximab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

TARGETDNA
YMonoclonal antibody
CATALOGSC-BS-621
CATALOG NUMBERSC-BS-621
MOLECULAR WEIGHTLot-specific
PRODUCT FORMATMonoclonal antibody

A research-use configuration for comparative antibody studies

Derlotuximab is a CHO-expressed, scFv-Fc (huIgG1) type chimeric antibody that targets Histone H1. The predicted molecular weight (MW) of Derlotuximab is 145.1 kDa. The isotype control for Derlotuximab can be referenced as Human IgG1 kappa, Isotype Control (HY-P99001).

Derlotuximab is a recombinant research-use antibody directed against DNA.

START A CONVERSATION

Tell us about your research goals.

For quotes, sample requests or technical support, start with your target and experimental context.

Contact StellaCyte
Derlotuximab | StellaCyte